Does ELOTUZUMAB Cause Platelet count decreased? 82 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Platelet count decreased have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 2.4% of all adverse event reports for ELOTUZUMAB.
82
Reports of Platelet count decreased with ELOTUZUMAB
2.4%
of all ELOTUZUMAB reports
20
Deaths
37
Hospitalizations
How Dangerous Is Platelet count decreased From ELOTUZUMAB?
Of the 82 reports, 20 (24.4%) resulted in death, 37 (45.1%) required hospitalization, and 13 (15.9%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 82 reports have been filed with the FAERS database.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which ELOTUZUMAB Alternatives Have Lower Platelet count decreased Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE